SCHEMBL21716847

SCHEMBL21716847

c1ccc2c(-c3nc4ccccc4nc3-c3ccc4ccc5ccccc5c4c3)cc(-n3c4ccccc4c4cc5cc(-n6c7ccccc7c7ccccc76)ccc5cc43)cc2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HIF1A Q16665 1/20 0.33
CYP1B1 Q16678 1/20 0.33
HSD17B10 Q99714 1/20 0.33
F2 P00734 1/20 0.32
F10 P00742 1/20 0.32
PRSS1 P07477 1/20 0.32
TUBB4A P04350 1/20 0.31
TUBB P07437 1/20 0.31
TUBA3C P0DPH7 1/20 0.31
TUBA1B P68363 1/20 0.31
TUBA4A P68366 1/20 0.31
TUBB4B P68371 1/20 0.31
TUBB3 Q13509 1/20 0.31
TUBB2A Q13885 1/20 0.31
TUBB8 Q3ZCM7 1/20 0.31
TUBA3E Q6PEY2 1/20 0.31
TUBA1A Q71U36 1/20 0.31
TUBA1C Q9BQE3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21716479 1.00 HPGD (0.33) HPGDALDH1A1HIF1ACYP1B1HSD17B10
SCHEMBL21717029 0.94 F2 (0.32) HPGDF2F10PRSS1
SCHEMBL21717541 0.94 PTGES (0.32) HPGDF2F10PRSS1
SCHEMBL21716956 0.90 L3MBTL1 (0.36) HPGDALDH1A1HIF1ACYP1B1HSD17B10
SCHEMBL21716440 0.90 L3MBTL1 (0.36) HPGDALDH1A1HIF1ACYP1B1HSD17B10
SCHEMBL21716686 0.89 HPGD (0.36) HPGDF2F10PRSS1TUBB4A
SCHEMBL21716731 0.89 HPGD (0.36) HPGDF2F10PRSS1TUBB4A
SCHEMBL21716277 0.88 ALDH1A1 (0.33) HPGDALDH1A1HIF1ACYP1B1HSD17B10
SCHEMBL21716930 0.86 HPGD (0.33) HPGDALDH1A1HIF1ACYP1B1HSD17B10
SCHEMBL21716261 0.86 HPGD (0.33) HPGDALDH1A1HIF1ACYP1B1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 HPGD 652/4885ALDH1A1 33/4885HIF1A 1659/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 HPGD 652/4885ALDH1A1 33/4885HIF1A 1659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.